Giant cell tumor of soft parts is a rare tumor that is clinically and histologically similar to giant cell tumor of the bone. We present a 53-year-old female with a giant cell tumor of low malignant potential arising from the neck. The clinicopathological features and the importance of immunohistochemistry in the differential diagnosis with other giant cell rich tumors was discussed.
INTRODUCTION
Giant cell tumor of soft parts (GCTSP) is an extremely rare soft tissue tumor that resembles its counterpart in bone. It is considered a soft tissue counterpart of giant cell tumor of the bone (1-3). The tumor is composed of an admixture of osteoclast-like multinucleated giant cells and mononuclear stromal cells (3, 4) . The lesion was first described in 1972 by Salm and Sissons and Guccion and Enzinger (3, 4) . Salm and Sissons reported a series of 10 benign GCTSP which were analogous to giant cell tumor of bone (3) . However, in a series of thirty two cases, Guccian and Enzinger noticed that majority of the tumors exhibited agressive clinical behavior. Their study was the first to recognize malignant behavior in GCTSP (4) . This pathologic entity was later labeled "malignant fibrous histiocytoma, giant cell type" based on the fact that these tumors were linked histogenetically to malignant fibrous histiocytoma (2) . Later, Folpe et al. reported thirty-one additional cases with the same histopathologic features but yet lacking marked cytologic atypia and reclassified it as "giant cell tumor of low malignant potential" (5) . In their article, Folpe et al emphasize that some tumors may show mitotic activity and vascular invasion. Two additional major series of patients with GCTS have subsequently been reported (6, 7) . recently, tumors with similar histopathologic features have been described in numerous different anatomic sites including extremities, trunk, breast, and skin (5-10). Although many uncommon locations have been reported, the disease is rarely present in the head and neck (7, (11) (12) (13) (14) (15) (16) .
Here, we report a case of rare GCTSP arising in the neck and we describe the clinicopathologic features and discuss the importance of immunohistochemistry in the differential diagnosis with other giant cell rich tumors.
CASE REPORT
A 53-year-old woman was admitted to an outside hospital with the complaint of a slowly enlarging, non-tender left neck mass that had been present for approximately one year. Ultrasonography of the neck revealed a 3.3x2.3 cm, lobulated contoured, solitary mass containing hypoechoic areas ( Figure 1) . A computed tomography (CT) scan demonstrated a 4x3cm heterogenous, soft tissue mass with enhancing margins adjacent to the sternocleidomastoid muscle. To make a definite diagnosis, an incisional biopsy was performed. The histopathological diagnosis of the incisional biopsy was benign fibrohistiocytic Figure  2B ). Osteoclast-type giant cells with abundant eosinophilic to amphophilic cytoplasm and multiple vesicular nuclei with chromatin clumping were observed. In focal areas, oval plump mononuclear cells exhibited mild nuclear atypia ( Figure 2C ). Clusters of lymphocytes, plasma cells, and many macrophages containing hemosiderin were also noted. Osteoid and cartilaginous matrix were not seen.
Occasionally areas of haemorrhage were observed. Striking nuclear atypia, necrosis and atypical mitotic figures were not present in this lesion. All resection margins were clear of malignancy. Immunostainings for CD68, S-100 protein, pancytokeratin,
[alpha]-1-antitrypsin (AAT), lysozyme, and vimentin were performed using a sensitive biotin-streptavidin immunoperoxidase technique on 5µ paraffin sections. CD68 immunoreactivity was strong and diffuse in the multinucleated giant cells and focal in the mononuclear cells (Figure 3 ). mononuclear and multinucleated tumor cells were also positive for vimentin and alpha-1-antityripsin.
Immunohistochemically, lysozyme showed scattered positive spindle cells among negative giant cells. However, both giant cells and spindle cells were negative for S-100, cytokeratin (AE1), and smooth muscle actin. Based on the histopathological and immunohistochemical findings, the final diagnosis of the present case was soft tissue giant cell tumour of low malignant potential.
of a painless mass in the left posterior neck (17) . Likewise, we here describe a case of a GCTSP in the neck. Giant cell reparative granuloma or peripheral giant cell granuloma (PGCG) arises exclusively from the periodontal ligament enclosing the root of a tooth. This unique origin means that such a lesion can only be found within or upon the gingiva or alveolar ridge. Apart from the rather significant difference in location, giant cells in PGCG tend to have fewer nuclei and irregular shapes. They have propensity for clustering around areas of necrosis and haemorrhage, while those in GCTSP are more evenly distributed. There is an increased incidence of osteoid, haemorrhage, and hemosiderin in PGCG compared with GCTSP (1,2,20,21).
GCTSP should be considered different from giant cell rich malignant fibrous histiocytoma (mFH) because the latter is a more aggressive, high grade malignant tumor. Giant cell rich mFH is a multinodular, storiform-pleomorphic mFH with marked cytologic atypia, atypical mitoses, and benign osteoclast-like giant cells. However, GCTSP lack the numerous atypical mitoses and coagulative tumor cell necrosis typical of giant cell rich mFH. The current choice of treatment is to combine aggressive surgical resection and postoperative radiotherapy for these malignant tumors 
DISCUSSION
Although giant cell tumors of soft parts are very uncommon neoplasms, they have been described in numerous anotomic sites including extremities, trunk, superficial and deep fascia, tendon sheath, and skeletal muscle (2, (5) (6) (7) (8) (9) (10) . Head and neck tumors containing multinucleated giant cells are uncommon lesions in contrast to giant cell tumors that commonly arise in the bone. most of the time, GCTSP arises in the extremities, thigh and trunk, but very rarely it arises in the head and neck localization (7, (11) (12) (13) (14) (15) (16) The differential diagnosis also includes plexiform fibrohistiocytic tumor (PFT). Dermal/subcutaneous location, and identification of bimodal population of cells in these tumors often allows for its distinction. Unlike GCTSP, which shows coarser multinodular pattern, PFT reveals plexiform growth pattern with minute nodules or short facicles of fibroblasts at the dermal subcutaneous interface. In addition, PFT tends to arise in younger patients in a truncal location (1, 2, 20 Although histologic characteristics of giant cell tumor suggest a mesenchymal origin, the histogenesis is still unknown. The giant cells resemble osteoclasts both microscopically and ultrastructurally. They also have a certain content of hydrolytic enzymes such as acid phosphatase. recently, some studies have confirmed the osteoclastic nature of giant cells in giant-cell-rich mFH and have shown that osteoclasts are also present in the GCTSP of low-grade malignant potential (22) .
The treatment of GCTSP remains controversial because of the small number of reported cases. radical surgery has been widely accepted as a mode of treatment for GCTSP. However, because of the possibility of local recurrence, clinical follow up with or without postoperative radiotherapy is advised after excision. Although some authors advocate adjuvant radiotherapy as a treatment of GCTSP, many aspects of this mode of treatment have not been clarified (15) . After a multidisciplinary discussion, postoperative radiotherapy was proposed. Our patient was given postoperative radiotherapy to the neck. The affected side of the ipsilateral neck was treated with opposed tangential fields. She received 5000 cGy in 25 fractions delivered over a period 5 weeks.
In patients with clinical follow-up that ranges from 34 to 45 months, GCTSP was associated with a local recurrence rate of 12%, and very rare metastasis and death. No clinicopathologic factors are currently predictive of metastatic behaviour associated with GCTSP (1,6,7). Two years after surgical and radiotherapy treatment, our case was alive and showed no evidence of recurrence and or metastasis.
In conclusion, GCTSP should be kept in mind in the differential diagnosis of other osteoclast-like giant cell-rich tumors of the neck.
